Health Library

Hormone therapy for breast cancer

Hormonal therapy - breast cancer; Hormone treatment - breast cancer; Endocrine therapy; Hormone-sensitive cancers - therapy; ER positive - therapy; Aromatase inhibitors - breast cancer

Hormone therapy to treat breast cancer uses medicines or treatments to lower levels or block the action of female sex hormones (estrogen and progesterone) in a woman's body. This helps slow the growth of many breast cancers.

Hormone therapy can make cancer less likely to return after breast cancer surgery. It also may slow the growth of breast cancer that has spread to other parts of the body.

I Would Like to Learn About:

Information

Hormone therapy can also be used to help prevent cancer in women at high risk for breast cancer. It is different from hormone therapy to treat menopause symptoms.

Hormones and Breast Cancer

The hormones estrogen and progesterone make some breast cancers grow. They are called hormone-sensitive breast cancers. Most breast cancers are sensitive to hormones.

Estrogen and progesterone are produced in the ovaries and other tissues such as fat and skin. After menopause, the ovaries stop producing these hormones. But the body continues to make small amounts.

Hormone therapy only works on hormone-sensitive cancers. To see if hormone therapy may work, doctors test a sample of the tumor that has been removed during surgery to see if the cancer might be sensitive to hormones.

Hormone therapy can work in two ways:

• By blocking the estrogen from acting on cancer cells
• By lowering estrogen levels in a woman's body

Drugs That Block Estrogen

Some medicines work by blocking estrogen from causing cancer cells to grow.

Tamoxifen (Nolvadex) is a medicine that prevents estrogen from telling cancer cells to grow. It has a number of benefits:

• Taking tamoxifen for 5 years after breast cancer surgery cuts the chance of cancer coming back by half. Some studies show that taking it for 10 years may work even better.
• It reduces the risk that cancer will occur in the other breast.
• It slows the growth and shrinks cancer that has spread.
• It reduces the risk of getting cancer in women who are at high risk for cancer but don't actually have it.

Other medicines that work in a similar way are used to treat advanced cancer that has spread:

• Toremifene (Fareston)
• Fulvestrantfene (Faslodex)
• Elacestrant (Ordserdu)

Drugs That Lower Estrogen Levels

Some medicines, called aromatase inhibitors (AIs), stop the body from making estrogen in tissues such as fat and skin. But, these medicines do not work to make the ovaries stop making estrogen. For this reason, they are used mainly to lower estrogen levels in women who have been through menopause (postmenopausal). Their ovaries no longer make estrogen.

Premenopausal women can take AIs if they are also taking medicines that stop their ovaries from making estrogen.

Aromatase inhibitors include:

• Anastrozole (Arimidex)
• Letrozole (Femara)
• Exemestane (Aromasin)

Lowering Estrogen Levels From the Ovaries

This type of treatment only works in premenopausal women who have functioning ovaries. It can help some types of hormone therapy work better. It is also used to treat cancer that has spread.

There are three ways to lower estrogen levels from the ovaries:

• Surgery to remove the ovaries
• Radiation to damage the ovaries so they no longer function, which is permanent
• Medicines such as goserelin (Zoladex) and leuprolide (Lupron) that temporarily stop the ovaries from making estrogen

Any of these methods will put a woman into menopause. This causes symptoms of menopause:

• Hot flashes
• Night sweats
• Vaginal dryness
• Mood swings
• Depression
• Loss of interest in sex

Drug Side Effects

The side effects of hormone therapy depend on the medicine. Common side effects include hot flashes, night sweats, and vaginal dryness.

Some medicines can cause less common but more serious side effects, such as:

• Tamoxifen. Blood clots, stroke, cataracts, endometrial and uterine cancers, mood swings, depression, and loss of interest in sex.
• Aromatase inhibitors. High cholesterol, heart attack, bone loss, joint pain, mood swings, and depression.
• Fulvestrant.Loss of appetite, nausea, vomiting, constipation, diarrhea, stomach pain, weakness, and pain.

Weighing the Options

Deciding on hormonal therapy for breast cancer can be a complex and even difficult decision. The type of therapy you receive may depend on whether you have gone through menopause before treatment for breast cancer. It also may depend on whether you want to become pregnant. Talking with your health care provider about your options and the benefits and risks for each treatment can help you make the best decision for you.

References

American Cancer Society website. Hormone therapy for breast cancer. www.cancer.org/cancer/types/breast-cancer/treatment/hormone-therapy-for-breast-cancer.html. Updated September 28, 2025. Accessed December 15, 2025.

Burstein HJ, Somerfield MR, Barton DL, et al. Endocrine Treatment and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: ASCO Guideline Update. J Clin Oncol. 2021;39(35):3959-3977. PMID: 34324367 pubmed.ncbi.nlm.nih.gov/34324367/.

Davidson NE. Breast cancer and benign breast disorders. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 183.

Henry NL, Shah PD, Haider I, Freer PE, Jagsi R, Sabel MS. Cancer of the breast. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 88.

National Cancer Institute website. Breast cancer treatment (PDQ®) - health professional version. www.cancer.gov/types/breast/hp/breast-treatment-pdq. Updated April 25, 2025. Accessed December 15, 2025.

Review Date: 10/21/2025  

Reviewed By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- 2026 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.